Evidence map›Paper›PMID 38302953›Full record

ReviewCell communication and signaling : CCS2024

Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets.

Zihong Wu, Chong Xiao, Jing Long, Wenbo Huang, Fengming You, Xueke Li

Open access · goldAbstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Ramucirumab induces apoptosis in Caco-2 cells via mitochondrial impairment and caspase activation.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zihong WuHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.ORCID 0000-0002-4879-8897
Chong XiaoHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
Jing LongHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
Wenbo HuangHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
Fengming YouHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China. yfmdoc@163.com.
Xueke LiHospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China. 2017202040046@whu.edu.cn.ORCID 0000-0003-3937-1274
Chengdu University of Traditional Chinese Medicine · CN

Funding

China Postdoctoral Science Foundation 2022MD723718National Natural Science Foundation of China 82205072
6 · The paper itself

Abstract

Colorectal cancer (CRC) is a significant public health concern, and its development is associated with mitochondrial dysfunction. Mitochondria can adapt to the high metabolic demands of cancer cells owing to their plasticity and dynamic nature. The fusion-fission dynamics of mitochondria play a crucial role in signal transduction and metabolic functions of CRC cells. Enhanced mitochondrial fission promotes the metabolic reprogramming of CRC cells, leading to cell proliferation, metastasis, and chemoresistance. Excessive fission can also trigger mitochondria-mediated apoptosis. In contrast, excessive mitochondrial fusion leads to adenosine triphosphate (ATP) overproduction and abnormal tumor proliferation, whereas moderate fusion protects intestinal epithelial cells from oxidative stress-induced mitochondrial damage, thus preventing colitis-associated cancer (CAC). Therefore, an imbalance in mitochondrial dynamics can either promote or inhibit CRC progression. This review provides an overview of the mechanism underlying mitochondrial fusion-fission dynamics and their impact on CRC biology. This revealed the dual role of mitochondrial fusion-fission dynamics in CRC development and identified potential drug targets. Additionally, this study partially explored mitochondrial dynamics in immune and vascular endothelial cells in the tumor microenvironment, suggesting promising prospects for targeting key fusion/fission effector proteins against CRC.

Indexed as

Colorectal NeoplasmsMitochondrial DynamicsEndothelial CellsHumansMitochondriaMitochondrial ProteinsSignal TransductionTumor MicroenvironmentMitochondrial ProteinsColorectal cancerDrug targetsFusion–fissionMitochondrial dynamics

Identifiers

PMID38302953
PMCPMC10835948
OpenAlexW4391449968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.